关注
Philippe Lucas PhD
Philippe Lucas PhD
在 uvic.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada
G Thomas, P Lucas, NR Capler, KW Tupper, G Martin
Curr Drug Abuse Rev 6 (1), 30-42, 2013
4062013
Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use
Z Walsh, R Callaway, L Belle-Isle, R Capler, R Kay, P Lucas, S Holtzman
International Journal of Drug Policy 24 (6), 511-516, 2013
3622013
Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients
P Lucas, Z Walsh
International Journal of Drug Policy 42, 30-35, 2017
3032017
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
EP Baron, P Lucas, J Eades, O Hogue
The journal of headache and pain 19, 1-28, 2018
2152018
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors
P Lucas, Z Walsh, K Crosby, R Callaway, L Belle‐Isle, R Kay, R Capler, ...
Drug and alcohol review 35 (3), 326-333, 2016
1722016
Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain
P Lucas
Journal of psychoactive drugs 44 (2), 125-133, 2012
1642012
Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against ‘morning sickness’
RE Westfall, PA Janssen, P Lucas, R Capler
Complementary Therapies in Clinical Practice 12 (1), 27-33, 2006
1612006
Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of …
P Lucas, EP Baron, N Jikomes
Harm reduction journal 16, 1-11, 2019
1372019
Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients
P Lucas, A Reiman, M Earleywine, SK McGowan, M Oleson, MP Coward, ...
Addiction Research & Theory 21 (5), 435-442, 2013
1342013
A ‘standard joint’? The role of quantity in predicting cannabis-related problems
C Zeisser, K Thompson, T Stockwell, C Duff, C Chow, K Vallance, A Ivsins, ...
Addiction Research & Theory 20 (1), 82-92, 2012
1322012
Rationale for cannabis-based interventions in the opioid overdose crisis
P Lucas
Harm reduction journal 14, 1-6, 2017
1192017
Barriers to access for Canadians who use cannabis for therapeutic purposes
L Belle-Isle, Z Walsh, R Callaway, P Lucas, R Capler, R Kay, S Holtzman
International Journal of Drug Policy 25 (4), 691-699, 2014
1172014
Exploring ayahuasca‐assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada
E Argento, R Capler, G Thomas, P Lucas, KW Tupper
Drug and alcohol review 38 (7), 781-789, 2019
892019
Regulating compassion: An overview of Canada's federal medical cannabis policy and practice
PG Lucas
Harm Reduction Journal 5, 1-13, 2008
782008
Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of Canadian medicinal cannabis users
J Turna, W Simpson, B Patterson, P Lucas, M Van Ameringen
Journal of psychiatric research 111, 134-139, 2019
672019
Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance use
Z Walsh, PS Hendricks, S Smith, DS Kosson, MS Thiessen, P Lucas, ...
Journal of Psychopharmacology 30 (7), 601-607, 2016
642016
Cannabis significantly reduces the use of prescription opioids and improves quality of life in authorized patients: results of a large prospective study
P Lucas, S Boyd, MJ Milloy, Z Walsh
Pain Medicine 22 (3), 727-739, 2021
572021
Are dispensaries indispensable? Patient experiences of access to cannabis from medical cannabis dispensaries in Canada
R Capler, Z Walsh, K Crosby, L Belle-Isle, S Holtzman, P Lucas, ...
International Journal of Drug Policy 47, 1-8, 2017
542017
It can't hurt to ask; a patient-centered quality of service assessment of health canada's medical cannabis policy and program
P Lucas
Harm Reduction Journal 9, 1-11, 2012
382012
Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice
P Lucas
International Journal of Drug Policy 20 (4), 296-303, 2009
382009
系统目前无法执行此操作,请稍后再试。
文章 1–20